Should Biotechnology Stock Arcturus Therapeutics Holdings Inc (ARCT) Be in Your Portfolio Thursday?

A rating of 91 puts Arcturus Therapeutics Holdings Inc (ARCT) near the top of the Biotechnology industry according to InvestorsObserver. Arcturus Therapeutics Holdings Inc's score of 91 means it scores higher than 91% of stocks in the industry. Arcturus Therapeutics Holdings Inc also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 21 out of the 148 industries.

ARCT has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on ARCT!

See Full ARCT Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 78 would rank higher than 78 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?

Arcturus Therapeutics Holdings Inc (ARCT) stock is trading at $33.53 as of 11:58 AM on Thursday, Mar 21, a gain of $0.38, or 1.13% from the previous closing price of $33.15. The stock has traded between $33.32 and $34.13 so far today. Volume today is less active than usual. So far 82,933 shares have traded compared to average volume of 502,635 shares. Click Here to get the full Stock Report for Arcturus Therapeutics Holdings Inc stock.